Papillomavirus Infections
"Papillomavirus Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.
Descriptor ID |
D030361
|
MeSH Number(s) |
C02.256.650 C02.928.725
|
Concept/Terms |
Papillomavirus Infections- Papillomavirus Infections
- Papillomavirus Infection
- HPV Infection
- HPV Infections
- Human Papillomavirus Infection
- Human Papillomavirus Infections
- Papillomavirus Infection, Human
- Papillomavirus Infections, Human
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Infections".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Infections".
- Papillomavirus Infections
- Warts
This graph shows the total number of publications written about "Papillomavirus Infections" by people in this website by year, and whether "Papillomavirus Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2009 | 3 | 0 | 3 |
2010 | 2 | 1 | 3 |
2011 | 3 | 0 | 3 |
2012 | 3 | 0 | 3 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 1 | 1 | 2 |
2017 | 3 | 0 | 3 |
2018 | 7 | 1 | 8 |
2019 | 7 | 0 | 7 |
2020 | 4 | 0 | 4 |
2021 | 3 | 1 | 4 |
2022 | 4 | 0 | 4 |
2023 | 2 | 0 | 2 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Infections" by people in Profiles.
-
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection. AIDS Res Ther. 2024 Dec 30; 21(1):101.
-
High prevalence of human papillomavirus (HPV) in unvaccinated adolescent girls in South Africa, particularly those living with HIV. Vaccine. 2024 Dec 02; 42(26):126442.
-
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries. Clin Epigenetics. 2024 Apr 20; 16(1):56.
-
Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Int J Cancer. 2024 Jul 15; 155(2):251-260.
-
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study. Int J Cancer. 2024 Jan 15; 154(2):284-296.
-
No woman left behind: achieving cervical cancer elimination among women living with HIV. Lancet HIV. 2023 06; 10(6):e412-e420.
-
Prevention of Cervical Cancer in Low-Resource African Settings. Obstet Gynecol Clin North Am. 2022 Dec; 49(4):771-781.
-
Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies. BMC Public Health. 2022 08 10; 22(1):1530.
-
Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design. BMJ Open. 2022 Feb 10; 12(2):e059968.
-
Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization. AIDS. 2022 02 01; 36(2):257-265.